Delivery Order SPE2DB22D3301-SPE2DB26FX3YE
- Not listed
- The Defense Logistics Agency awarded a $1,202.68 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ultane 250 ml pen bottles. This firm fixed price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,443.90 delivery order to AmerisourceBergen Drug Corp for 250 ml of Ultane in a pen bottle configuration, with an ultimate completion date of October 17, 2025. This is a firm fixed price, competitively awarded order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,679.89 on September 17, 2025, for the supply of Ultane 250 ML in pen bottle format. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for Ultane Liquid 250ML with a ceiling value of $3,202.32. This firm fixed-price, non-set-aside delivery order is scheduled for ultimate completion on May 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ultane Liquid 250ML, with a firm fixed price ceiling value of $2,816.90 and completion targeted for August 19, 2025. This competitively awarded, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with the Defense Logistics Agency Troop Support Medical, valued at...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,443.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ultane Liquid 250mL on September 16, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The work will be performed at the contractor's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,828.94 to AmerisourceBergen Drug Corp for the supply of Ultane 250 mL pen bottles. This firm fixed-price, non-set-aside contract was awarded on June 16, 2025, with an ultimate completion date of June 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill this...
- The Defense Logistics Agency awarded a $1,299.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 250 milliliters of Ultane in pen bottle format, with a completion date of August 22, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and place of performance. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,667.16 award is for the supply of ULTANE 250 ML PEN BOTTLE 250ML pharmaceutical products to support military treatment programs and facilities. Amerisourcebergen Drug Corporation holds an indefinite delivery contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,689.25 firm fixed-price contract is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product. The contract has a period of performance through November 13, 2024 and is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3YEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,484.61 to AmerisourceBergen Drug Corp for ULTANE 250 ML pen bottles on October 28, 2025, with completion targeted for October 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and serves as a major pharmaceutical distributor for federal medical procurement. AmerisourceBergen Drug Corp functions as a critical vendor within the federal medical supply chain, leveraging its IDC to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's extensive portfolio includes brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains. This delivery order for ULTANE falls within the scope of the company's established relationship with DLA and demonstrates its capability to fulfill federal medical supply requirements through open competition, consistent with its track record of diverse contract awards ranging from sub-$100 transactions to orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/28/25 |